October 2022
-
10.31.2022 Covid-19 Health Equity Partnerships Vaccines Amid COVID-19 Global Pandemic, The Pfizer Foundation Helps IRC Pursue Urgent Expansion of Health Access in Humanitarian Settings
September 2021
-
09.16.2021 Perspectives Albert Bourla Covid-19 Diseases & Conditions Vaccines Continuing to Follow the Science: An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla
May 2021
-
05.07.2021 Perspectives Albert Bourla Covid-19 Diseases & Conditions Vaccines An Open Letter from Pfizer Chairman and CEO to Colleagues
March 2021
-
03.09.2021 Perspectives Albert Bourla Business Clinical Trials Covid-19 Diseases & Conditions Leadership mRNA Partnerships Patient Centricity Technology Vaccines Wellness Albert Bourla Reflects on the One Year Anniversary of the COVID-19 Pandemic
January 2021
-
01.22.2021 Perspectives Albert Bourla Business Covid-19 Diseases & Conditions mRNA Partnerships Patient Centricity Responsibility Vaccines Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines
December 2020
-
12.15.2020 Perspectives Albert Bourla Covid-19 COVID-19 Vaccine Efforts Diseases & Conditions Vaccines Distributing Our COVID-19 Vaccine to the World
October 2020
-
10.15.2020 Perspectives Albert Bourla Covid-19 Diseases & Conditions Vaccines An Open Letter from Pfizer Chairman and CEO Albert Bourla